Role of CX3CR1 Receptor in Monocyte/Macrophage Driven Neovascularization

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Kumar, Arun H S ^a   Martin, Kenneth ^a   Turner, Elizebeth C ^a   Buneker, Chirlei K ^a   Dorgham, Karim ^b   Deterre, Philippe ^b   Caplice, Noel M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; GREEN FLUORESCENT PROTEIN; LAMININ; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; CHEMOKINE RECEPTOR; COLLAGEN; CX3CR1 PROTEIN, MOUSE; MATRIGEL; PEPTIDE; PROTEIN KINASE INHIBITOR; PROTEOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROGENESIS; BASEMENT MEMBRANE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; EXTRAVASATION; GENE DELETION; IN VIVO STUDY; INTRACELLULAR SIGNALING; MACROPHAGE; MALE; MONOCYTE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL MOTION; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MICROVASCULATURE; PATHOLOGY; REPORTER GENE; THROMBOCYTE; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; CAPILLARY PERMEABILITY; CELL MOVEMENT; CHEMOKINE CX3CL1; COLLAGEN; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; LAMININ; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROVESSELS; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PROTEIN KINASE INHIBITORS; PROTEOGLYCANS; RECEPTORS, CHEMOKINE;

MLCS; MLOWN;

EID: 84874322903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057230     Document Type: Article

References (47)

1. Angelillo-Scherrer A, (2012) Leukocyte-derived microparticles in vascular homeostasis. Circ Res 110: 356-369.
2. Swirski FK, Weissleder R, Pittet MJ, (2009) Heterogeneous in vivo behavior of monocyte subsets in atherosclerosis. Arterioscler Thromb Vasc Biol 29: 1424-1432.
3. Weber C, Zernecke A, Libby P, (2008) The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 8: 802-815.
4. Anghelina M, Krishnan P, Moldovan L, Moldovan NI, (2006) Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168: 529-541.
5. Finn AV, Jain RK, (2010) Coronary plaque neovascularization and hemorrhage: a potential target for plaque stabilization? JACC Cardiovasc Imaging 3: 41-44.
6. Jain RK, Finn AV, Kolodgie FD, Gold HK, Virmani R, (2007) Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization. Nat Clin Pract Cardiovasc Med 4: 491-502.
7. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
8. Lucerna M, Zernecke A, de Nooijer R, de Jager SC, Bot I, et al. (2007) Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment. Blood 109: 122-129.
9. Lobov IB, Rao S, Carroll TJ, Vallance JE, Ito M, et al. (2005) WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature 437: 417-421.
10. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
11. Kumar AH, Caplice NM, (2010) Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 30: 1080-1087.
12. Moldovan NI, (2002) Role of monocytes and macrophages in adult angiogenesis: a light at the tunnel's end. J Hematother Stem Cell Res 11: 179-194.
13. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy PE, (2000) Contribution of monocytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87: 378-384.
14. Tigges U, Hyer EG, Scharf J, Stallcup WB, (2008) FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development 135: 523-532.
15. Goichberg P, Bai Y, D'Amario D, Ferreira-Martins J, Fiorini C, et al. (2011) The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circ Res 108: 1071-1083.
16. Metharom P, Kumar AH, Weiss S, Caplice NM, (2010) A specific subset of mouse bone marrow cells has smooth muscle cell differentiation capacity-brief report. Arterioscler Thromb Vasc Biol 30: 533-535.
17. Kumar AH, Metharom P, Schmeckpeper J, Weiss S, Martin K, et al. (2010) Bone marrow-derived CX3CR1 progenitors contribute to neointimal smooth muscle cells via fractalkine CX3CR1 interaction. FASEB J 24: 81-92.
18. Lesnik P, Haskell CA, Charo IF, (2003) Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. J Clin Invest 111: 333-340.
19. Liu P, Patil S, Rojas M, Fong AM, Smyth SS, et al. (2006) CX3CR1 deficiency confers protection from intimal hyperplasia after arterial injury. Arterioscler Thromb Vasc Biol 26: 2056-2062.
20. Pamukcu B, Lip GY, Devitt A, Griffiths H, Shantsila E, (2010) The role of monocytes in atherosclerotic coronary artery disease. Ann Med 42: 394-403.
21. Lee SJ, Namkoong S, Kim YM, Kim CK, Lee H, et al. (2006) Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways. Am J Physiol Heart Circ Physiol 291: H2836-2846.
22. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, et al. (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117: 2920-2928.
23. Jung S, Aliberti J, Graemmel P, Sunshine MJ, Kreutzberg GW, et al. (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20: 4106-4114.
24. Dorgham K, Ghadiri A, Hermand P, Rodero M, Poupel L, et al. (2009) An engineered CX3CR1 antagonist endowed with anti-inflammatory activity. J Leukoc Biol 86: 903-911.
25. Haskell CA, Cleary MD, Charo IF, (1999) Molecular uncoupling of fractalkine-mediated cell adhesion and signal transduction. Rapid flow arrest of CX3CR1-expressing cells is independent of G-protein activation. J Biol Chem 274: 10053-10058.
26. Sasaki T, Kuzuya M, Nakamura K, Cheng XW, Shibata T, et al. (2006) A simple method of plaque rupture induction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 26: 1304-1309.
27. Sinclair PR, Gorman N, Jacobs JM, (2001) Measurement of heme concentration. Curr Protoc Toxicol Chapter 8: Unit 8 3.
28. Ryu J, Lee CW, Hong KH, Shin JA, Lim SH, et al. (2008) Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Cardiovasc Res 78: 333-340.
29. Bryan BA, D'Amore PA, (2007) What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci 64: 2053-2065.
30. Bell SE, Mavila A, Salazar R, Bayless KJ, Kanagala S, et al. (2001) Differential gene expression during capillary morphogenesis in 3D collagen matrices: regulated expression of genes involved in basement membrane matrix assembly, cell cycle progression, cellular differentiation and G-protein signaling. J Cell Sci 114: 2755-2773.
31. Nucera S, Biziato D, De Palma M, (2011) The interplay between macrophages and angiogenesis in development, tissue injury and regeneration. Int J Dev Biol 55: 495-503.
32. Fantin A, Vieira JM, Gestri G, Denti L, Schwarz Q, et al. (2010) Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood 116: 829-840.
33. Anghelina M, Krishnan P, Moldovan L, Moldovan NI, (2004) Monocytes and macrophages form branched cell columns in matrigel: implications for a role in neovascularization. Stem Cells Dev 13: 665-676.
34. White GE, Tan TC, John AE, Whatling C, McPheat WL, et al. (2010) Fractalkine has anti-apoptotic and proliferative effects on human vascular smooth muscle cells via epidermal growth factor receptor signalling. Cardiovasc Res 85: 825-835.
35. Landsman L, Bar-On L, Zernecke A, Kim KW, Krauthgamer R, et al. (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113: 963-972.
36. Martin K, Weiss S, Metharom P, Schmeckpeper J, Hynes B, et al. (2009) Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin. Circ Res 105: 214-218.
37. Schnoor M, Cullen P, Lorkowski J, Stolle K, Robenek H, et al. (2008) Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J Immunol 180: 5707-5719.
38. Khalil N, Bereznay O, Sporn M, Greenberg AH, (1989) Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 170: 727-737.
39. Murray PJ, Wynn TA, (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
40. Sprague L, Muccioli M, Pate M, Meles E, McGinty J, et al. (2011) The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. BMC Immunol 12: 35.
41. Pedraza C, Geberhiwot T, Ingerpuu S, Assefa D, Wondimu Z, et al. (2000) Monocytic cells synthesize, adhere to, and migrate on laminin-8 (alpha 4 beta 1 gamma 1). J Immunol 165: 5831-5838.
42. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, et al. (2008) ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 102: 1192-1201.
43. Newby AC, (2005) Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85: 1-31.
44. Rader DJ, Daugherty A, (2008) Translating molecular discoveries into new therapies for atherosclerosis. Nature 451: 904-913.
45. Doyle B, Caplice N, (2007) Plaque neovascularization and antiangiogenic therapy for atherosclerosis. J Am Coll Cardiol 49: 2073-2080.
46. Sasaki T, Nakamura K, Kuzuya M, (2007) Plaque rupture model in mice. Methods Mol Med 139: 67-75.
47. Daher IN, Yeh ET, (2008) Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med 5: 797-805.